Brief: Moberg Pharma Q2 Oper Loss At SEK 9.7 Mln

Moberg Pharma AB (publ)

12/08/2025 07:06

Aug 12 (Reuters) - Moberg Pharma AB (publ) MBPH.ST:

Q2 EBITDA SEK -9.3 MILLION (-5.2)

Q2 OPERATING PROFIT (EBIT) SEK -9.7 MILLION (-5.5)

Q2 NET REVENUE SEK 3.6 MILLION (4.1)

Source text: ID:nWkr2V4gsc

Further company coverage: MBPH.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))